ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 93 filers reported holding ADURO BIOTECH INC in Q3 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $94,000 | -31.4% | 89,000 | 0.0% | 0.00% | – |
| Q2 2019 | $137,000 | -53.1% | 89,000 | +21.4% | 0.00% | – |
| Q1 2019 | $292,000 | +50.5% | 73,300 | 0.0% | 0.00% | – |
| Q4 2018 | $194,000 | -64.0% | 73,300 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $539,000 | +5.1% | 73,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $513,000 | -4.1% | 73,300 | +27.5% | 0.00% | 0.0% |
| Q1 2018 | $535,000 | +41.9% | 57,500 | +14.3% | 0.00% | – |
| Q4 2017 | $377,000 | -29.7% | 50,300 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $536,000 | -6.5% | 50,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $573,000 | +38.4% | 50,300 | +30.6% | 0.00% | 0.0% |
| Q1 2017 | $414,000 | -5.7% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $439,000 | -8.4% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $479,000 | +10.1% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $435,000 | -8.8% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $477,000 | -46.7% | 38,500 | +21.1% | 0.00% | -50.0% |
| Q4 2015 | $895,000 | – | 31,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |